DDW Editor Reece Armstrong speaks to Dr. Zachary Gurard-Levin, CEO and Founder of Peapod Bio about challenges in small molecule drug discovery and what technologies are advancing this sector.    RA: What are the biggest challenges facing small molecule drug discovery and development?  ZG: The challenge that we continue to hear is attrition rate, where roughly […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!